Imperial College London
Portrait Picture

ProfessorRohiniSharma

Faculty of Medicine, Department of Surgery & Cancer

Professor Clinical Pharmacology and Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 3313 3059r.sharma Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fulgenzi:2022:10.1016/j.ejca.2022.08.024,
author = {Fulgenzi, CAM and Cheon, J and D'Alessio, A and Nishida, N and Ang, C and Marron, TU and Wu, L and Saeed, A and Wietharn, B and Cammarota, A and Pressiani, T and Personeni, N and Pinter, M and Scheiner, B and Balcar, L and Napolitano, A and Huang, Y-H and Phen, S and Naqash, AR and Vivaldi, C and Salani, F and Masi, G and Bettinger, D and Vogel, A and Schoenlein, M and von, Felden J and Schulze, K and Wege, H and Galle, PR and Kudo, M and Rimassa, L and Singal, AG and Sharma, R and Cortellini, A and Gaillard, VE and Chon, HJ and Pinato, DJ},
doi = {10.1016/j.ejca.2022.08.024},
journal = {EUROPEAN JOURNAL OF CANCER},
pages = {204--213},
title = {Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study},
url = {http://dx.doi.org/10.1016/j.ejca.2022.08.024},
volume = {175},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Fulgenzi,CAM
AU  - Cheon,J
AU  - D'Alessio,A
AU  - Nishida,N
AU  - Ang,C
AU  - Marron,TU
AU  - Wu,L
AU  - Saeed,A
AU  - Wietharn,B
AU  - Cammarota,A
AU  - Pressiani,T
AU  - Personeni,N
AU  - Pinter,M
AU  - Scheiner,B
AU  - Balcar,L
AU  - Napolitano,A
AU  - Huang,Y-H
AU  - Phen,S
AU  - Naqash,AR
AU  - Vivaldi,C
AU  - Salani,F
AU  - Masi,G
AU  - Bettinger,D
AU  - Vogel,A
AU  - Schoenlein,M
AU  - von,Felden J
AU  - Schulze,K
AU  - Wege,H
AU  - Galle,PR
AU  - Kudo,M
AU  - Rimassa,L
AU  - Singal,AG
AU  - Sharma,R
AU  - Cortellini,A
AU  - Gaillard,VE
AU  - Chon,HJ
AU  - Pinato,DJ
DO  - 10.1016/j.ejca.2022.08.024
EP  - 213
PY  - 2022///
SN  - 0959-8049
SP  - 204
TI  - Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
T2  - EUROPEAN JOURNAL OF CANCER
UR  - http://dx.doi.org/10.1016/j.ejca.2022.08.024
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:001044777600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 175
ER  -
Download